Sorafenib in malignant mesothelioma (MM): A phase II trial of the Cancer and Leukemia Group B (CALGB 30307) Meeting Abstract
| Authors: | Janne, P. A.; Wang, X. F.; Krug, L. M.; Hodgson, L.; Vokes, E. E.; Kindler, H. L. |
| Abstract Title: | Sorafenib in malignant mesothelioma (MM): A phase II trial of the Cancer and Leukemia Group B (CALGB 30307) |
| Meeting Title: | 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 25 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2007 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2007-06-20 |
| Start Page: | 435s |
| Language: | English |
| ACCESSION: | WOS:000455043702102 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2007.25.18_suppl.7707 |
| Notes: | Meeting Abstract: 7707 -- Source: Wos |
